BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24639112)

  • 1. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learnings from Protein Folding Projected onto Amyloid Misfolding.
    Sreenivasan S; Narayan M
    ACS Chem Neurosci; 2019 Sep; 10(9):3911-3913. PubMed ID: 31456389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry.
    Williams DM; Pukala TL
    Mass Spectrom Rev; 2013; 32(3):169-87. PubMed ID: 23345084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected aspects of amyloidogenesis].
    Stepkowski D
    Postepy Biochem; 2012; 58(1):110-4. PubMed ID: 23214135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding in disease and small molecule therapies.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.
    Pey AL
    Amino Acids; 2013 Dec; 45(6):1331-41. PubMed ID: 24178766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?
    Tipping KW; van Oosten-Hawle P; Hewitt EW; Radford SE
    Trends Biochem Sci; 2015 Dec; 40(12):719-727. PubMed ID: 26541462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of amyloid assembly by autoregulation.
    Landreh M; Johansson J; Rising A; Presto J; Jörnvall H
    Biochem J; 2012 Oct; 447(2):185-92. PubMed ID: 23013511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoimaging for protein misfolding diseases.
    Lyubchenko YL; Kim BH; Krasnoslobodtsev AV; Yu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):526-43. PubMed ID: 20665728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregation diseases: toxicity of soluble prefibrillar aggregates and their clinical significance.
    Stefani M
    Methods Mol Biol; 2010; 648():25-41. PubMed ID: 20700703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome.
    Masters SL; O'Neill LA
    Trends Mol Med; 2011 May; 17(5):276-82. PubMed ID: 21376667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.